BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 14755482)

  • 1. Matrix metalloproteinases and skeletal muscle: a brief review.
    Carmeli E; Moas M; Reznick AZ; Coleman R
    Muscle Nerve; 2004 Feb; 29(2):191-7. PubMed ID: 14755482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinases in skeletal muscles: friends or foes?
    Alameddine HS
    Neurobiol Dis; 2012 Dec; 48(3):508-18. PubMed ID: 22885251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases.
    Gueders MM; Foidart JM; Noel A; Cataldo DD
    Eur J Pharmacol; 2006 Mar; 533(1-3):133-44. PubMed ID: 16487964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The TIMPs tango with MMPs and more in the central nervous system.
    Crocker SJ; Pagenstecher A; Campbell IL
    J Neurosci Res; 2004 Jan; 75(1):1-11. PubMed ID: 14689443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis of the matrix metalloproteinases and their physiological inhibitors, the tissue inhibitors of metalloproteinases.
    Bode W; Maskos K
    Biol Chem; 2003 Jun; 384(6):863-72. PubMed ID: 12887053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biology of metalloproteinases.
    Amălinei C; Căruntu ID; Bălan RA
    Rom J Morphol Embryol; 2007; 48(4):323-34. PubMed ID: 18060181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular matrix remodelling: the role of matrix metalloproteinases.
    Stamenkovic I
    J Pathol; 2003 Jul; 200(4):448-64. PubMed ID: 12845612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation and localization of matrix metalloproteinase-2 and -9 in the skeletal muscle of the muscular dystrophy dog (CXMDJ).
    Fukushima K; Nakamura A; Ueda H; Yuasa K; Yoshida K; Takeda S; Ikeda S
    BMC Musculoskelet Disord; 2007 Jun; 8():54. PubMed ID: 17598883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metalloproteases and inhibitors in arthritic diseases.
    Martel-Pelletier J; Welsch DJ; Pelletier JP
    Best Pract Res Clin Rheumatol; 2001 Dec; 15(5):805-29. PubMed ID: 11812023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High intensity exercise increases expression of matrix metalloproteinases in fast skeletal muscle fibres.
    Carmeli E; Moas M; Lennon S; Powers SK
    Exp Physiol; 2005 Jul; 90(4):613-9. PubMed ID: 15833756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Matrix metalloproteinases and tissue inhibitors of metalloproteinases in the pathogenesis of rheumatoid arthritis].
    Fiedorczyk M; Klimiuk PA; Sierakowski S; Kita K
    Pol Merkur Lekarski; 2006 Feb; 20(116):228-31. PubMed ID: 16708647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure and function of matrix metalloproteinases and TIMPs.
    Nagase H; Visse R; Murphy G
    Cardiovasc Res; 2006 Feb; 69(3):562-73. PubMed ID: 16405877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of matrix metalloproteinases in melanoma cell invasion.
    Hofmann UB; Houben R; Bröcker EB; Becker JC
    Biochimie; 2005; 87(3-4):307-14. PubMed ID: 15781317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological activity and clinical implications of the matrix metalloproteinases.
    Rydlova M; Holubec L; Ludvikova M; Kalfert D; Franekova J; Povysil C; Ludvikova M
    Anticancer Res; 2008; 28(2B):1389-97. PubMed ID: 18505085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structures of MMPs in complex with physiological and pharmacological inhibitors.
    Maskos K
    Biochimie; 2005; 87(3-4):249-63. PubMed ID: 15781312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TIMPs as multifacial proteins.
    Lambert E; Dassé E; Haye B; Petitfrère E
    Crit Rev Oncol Hematol; 2004 Mar; 49(3):187-98. PubMed ID: 15036259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What has been learned about the cardiovascular effects of matrix metalloproteinases from mouse models?
    Janssens S; Lijnen HR
    Cardiovasc Res; 2006 Feb; 69(3):585-94. PubMed ID: 16426591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human matrix metalloproteinases: characteristics and pathologic role in altering mesangial homeostasis.
    Keeling J; Herrera GA
    Microsc Res Tech; 2008 May; 71(5):371-9. PubMed ID: 18300288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinases and their tissue inhibitors in hypertension-related pregnancy complications.
    Karthikeyan VJ; Lane DA; Beevers DG; Lip GY; Blann AD
    J Hum Hypertens; 2013 Feb; 27(2):72-8. PubMed ID: 22418748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinases, their production by monocytes and macrophages and their potential role in HIV-related diseases.
    Webster NL; Crowe SM
    J Leukoc Biol; 2006 Nov; 80(5):1052-66. PubMed ID: 16959898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.